| Literature DB >> 31464605 |
Getenet Dessie1, Desalegne Amare2, Amare Belachew Dagnew2, Henok Mulugeta3, Dessalegn Haile Kassa3, Ayenew Negesse4, Getachew Mullu Kassa5, Fasil Wagnew3, Sheikh Mohammed Shariful Islam6,7, Sahai Burrowes8.
Abstract
BACKGROUND: The distribution of goiter among children and its risk factors are not well investigated in Ethiopia. Therefore, this systematic review and meta-analysis was designed to determine the pooled prevalence of goiter and its associated factors among children in Ethiopia.Entities:
Keywords: Children; Ethiopia; Goiter; Meta-analysis
Mesh:
Year: 2019 PMID: 31464605 PMCID: PMC6716873 DOI: 10.1186/s12889-019-7505-7
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Risk of bias assessment of eligible articles using the hoy 2012 tool
| NO | Study ID | Representation | Sampling | Random selection | Non response bias | Data collection | Case Definition | Reliability and validity of study tool | Method of data collection | Prevalence period | Numerator and denominator | Summary Assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cherinet et al. | High risk | Low risk | High risk | Low risk | Low risk | High risk | High risk | High risk | low risk | Low risk | High risk |
| 2 | Cherinet et al. | High risk | Low risk | High risk | Low risk | Low risk | High risk | High risk | High risk | low risk | Low risk | High risk |
| 3 | Berhanu et al. | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 4 | Girma et al. | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 5 | Mezgebu et al. | Low risk | Low risk | High risk | Low risk | High risk | High risk | High risk | Low risk | Low risk | Low risk | High risk |
| 6 | Wolka E et al. | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 7 | Gebriel et al. | High risk | Low risk | High risk | Low risk | High risk | Low risk | High risk | Low risk | Low risk | Low risk | Medium risk |
| 8 | Mesele et al. | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 9 | Aweke KA et al. | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 10 | Kibatu et al. | High risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 11 | Enyew et al. | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 12 | Hailu et al. | High risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 13 | Sime HK et al. | High risk | Low risk | Low risk | High risk | High risk | High risk | High risk | Low risk | High risk | Low risk | High risk |
| 14 | Solomon E. | High risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 15 | Muleta et al. | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 16 | Hibstu DT et al. | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 17 | Tigabu E et al. | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 18 | Ahmed A et al. | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| 19 | Abebe et al. | High risk | Low risk | Low risk | High risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Medium risk |
Risk of bias assessment tool: Yes (low risk); No (high risk)
1. Representation: Was the study population a close representation of the national population?
2. Sampling: Was the sampling frame a true or close representation of the target population?
3. Random selection: Was some form of random selection used to select the sample OR was a census undertaken?
4. Non-response bias: Was the likelihood of non-response bias minimal?
5. Data collection: Were data collected directly from the subjects?
6. Case definition: Was an acceptable case definition used in the study?
7. Reliability and validity of study tool: Was the study instrument that measured the parameter of interest show to have reliability and validity?
8. Data collection: Was the same mode of data collection used for all subjects?
9. Prevalence period: Was the length of the prevalence period for the parameter of interest appropriate?
10. Numerators and denominators: Were the numerator(s) and denominator(s) for the parameter of interest appropriate?
The overall risk of bias scored based on the number of high risk of bias per study: low risk (≤2), moderate risk (3–4), and high risk (≥5)
Fig. 1PRISMA Flow diagram showing the procedure for selecting studies for meta-analysis, 2000–2017, Ethiopia
Characteristics of included studies for meta-analysis, 2000–2017, Ethiopia
| Authors name | Publication Year | Source Type | Region | Outcome definition criteria | Study design | Age of study participants (in years) | Response rate (%) | Sample size | Total n outcome | Prevalence (%) | Quality Score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cherinet A. et al. [ | 2000 | Journal | Oromia | WHO/UNICEF/ICIDD | Cross-sectional | 6–12 | 100 | 1825 | 664 | 36.4 | 6.5 |
| Cherinet A. et al. [ | 2000 | Journal | SNNPR | WHO/UNICEF/ICIDD | Cross-sectional | 6–12 | 100 | 660 | 515 | 78.03 | 6.5 |
| Berhanu N. et al. [ | 2004 | Journal | Oromia | WHO/UNICEF/ICCIDD | Cross-sectional | 6–15 | 100 | 1044 | 286 | 27.4 | 7 |
| Girma M. et al. [ | 2012 | Journal | SNNPR | WHO/ICCIDD/UNICEF | Cross-sectional | 7–9 | 94.80 | 110 | 15 | 13.6 | 6 |
| Mezgebu Y. et al. [ | 2012 | Journal | Oromia | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 100 | 389 | 230 | 59.1 | 7 |
| Wolka E. et al. [ | 2014 | Journal | SNNPR | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 100 | 534 | 270 | 50.6 | 7 |
| Gebriel T. et al. [ | 2014 | Journal | Benishangul Gumez | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 100 | 395 | 104 | 26.3 | 7 |
| Mesele M. et al. [ | 2014 | Journal | Amhara | WHO/ICCIDD/UNICEF | Cross-sectional | 6–12 | 99.42 | 694 | 261 | 37.6 | 6 |
| Aweke KA. et al. [ | 2014 | Journal | Amhara | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 100 | 513 | 281 | 54.7 | 7 |
| Kibatu G. et al. [ | 2014 | Journal | Amhara | WHO/UNICEF/ICCIDD | Cross-sectional | 6–18 | 100 | 200 | 79 | 39.5 | 7 |
| Enyew HD. et al. [ | 2015 | Journal | Oromia | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 98.20 | 397 | 200 | 50.6 | 6 |
| Hailu S. et al. [ | 2015 | Journal | Oromia | WHO criteria | Cross-sectional | 6–12 | 93.10 | 393 | 171 | 43.5 | 6.5 |
| Sime HK. et al. [ | 2015 | Journal | Oromia | WHO/UNICEF/ICCIDD | Cross-sectional | 6–12 | 94 | 709 | 264 | 37.2 | 7 |
| Emiru S. [ | 2016 | Institutional repository | Oromia | WHO/UNICEF/ICCIDD | Cross-sectional | 7–12 | 100 | 270 | 63 | 23.3 | 6 |
| Muleta F. et al. [ | 2016 | Journal | Benishangul Gumez | WHO/UNICEF/ICCIDD | Cross-sectional | 6–18 | 100 | 200 | 79 | 39.5 | 7 |
| Hibstu DT. et al. [ | 2017 | Journal | SNNPR | WHO | Cross-sectional | 6–12 | 99.40 | 358 | 126 | 35.2 | 7 |
| Tigabu E. et al. [ | 2017 | Journal | Amhara | WHO/UNICEF/ICCIDD | Cross-sectional | 7–12 | 97.60 | 443 | 275 | 62.1 | 7 |
| Ahmed A. et al. [ | 2017 | Journal | Amhara | WHO/UNICEF/ICCIDD | Cross-sectional | 6–15 | 100 | 384 | 113 | 29.1 | 7 |
| Abebe Z. et al. [ | 2017 | Journal | Amhara | WHO | Cross-sectional | 6–12 | 100 | 735 | 214 | 29.1 | 7 |
Fig. 2Meta funnel presentation of the prevalence of goiter among children, 2000–2017, Ethiopia
Fig. 3Forest plot showing the pooled prevalence of goiter in regions among male children in Ethiopia, 2000 to 2017
Distribution of goiter based on sex and region in studies conducted from 2000 to 2017, in Ethiopia
| Regions | Male | Female |
|---|---|---|
| Amhara | 31.7% (95% CI: 20.0–43.3) | 47% (95% CI: 30.1–63.8) |
| Oromia | 33.2% (95% CI: 23.3–43.1) | 44.4% (95% CI: 32.8–56%) |
| SNNPR | 42.1% (95% CI: 3.7–80.4) | 55.1% (95% CI: 13.6–92.6) |
| Benishangul Gumez | 22.21% (95% CI: 13.7–30.7) | 23.6% (95% CI: 19.2–28.0) |
Fig. 4Forest plot showing factors associated with goiter among children in Ethiopia, 2000 to 2017